Posts

Get An Update in Dermatology on Latest CME Webcast

OSUWexnerbloglogo2014 Get An Update in Dermatology on Latest CME Webcast. Dermatologic treatments have changed a lot since most of you did your residencies and so today, we are going to update you on some of these new developments so that you can provide your patients with the latest in therapeutics.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: better identify who you should send to a dermatologist to be screened for skin cancer; better recognize what types of skin lesions need biopsy or referral by a dermatologist; and describe psoriasis and current biologic agents, new treatment for atopic dermatitis, and new uses for older therapies frequently diagnosed first by the primary care physician.

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

On-line Education Teaches Physicians About Multiple Sclerosis

OSUWexnerbloglogo2014 On-line Education Teaches Physicians About Multiple Sclerosis. Over the past 25 years, there have been dramatic new developments in how we treat multiple sclerosis and this is giving hope to patients who on the past had very few options. Here today to bring us up to date on the latest developments in multiple sclerosis is the Chairman of the OSU Department of Neurology, Dr. Benjamin Segal.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: LEARN about the typicalclinical course of multiple sclerosis and disease modifying treatments; and LEARN about our current understanding of the pathogenesis of MS.

You’ll also learn about the following:

  • Common signs and symptoms of multiple sclerosis
  • Current concepts in multiple sclerosis treatment

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

CME Webcast Teaches on Multimodal Analgesia: Concepts and Strategies to Reduce Opioid Use

OSUWexnerbloglogo2014 CME Webcast Teaches on Multimodal Analgesia: Concepts and Strategies to Reduce Opioid Use. With the invention of the hypodermic syringe and hollow needle in 1850, morphine began to be used for surgical procedures and post-operative pain. However, many people became addicted to morphine so chemists set out to develop safer, more effective, and less addictive opioids. Thus heroin was created by the Bayer pharmaceutical company in 1898. That was followed by the synthesis of meperidine in 1939, methadone in 1946, and fentanyl in 1960. But all of these proved to be just as addictive as morphine. And this has left physicians in general and surgeons in particular with the dilemma of how do you relieve pain and suffering without causing the harm of addiction? Fortunately, we now have some guidance. Joining the webcast to tell us about strategies to treat pain while reducing opioid doses is OSU Professor of Plastic Surgery and the Past President of the American Society of Plastic Surgeons, Dr. Jeffrey Janis.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: UNDERSTAND the current epidemiology and causes of the current opioid crisis in the United States; Understand the current opioid prescribing practices for perioperative pain; and DEVELOP intra-operative and post-operative pain management strategies to reduce opioid use.

You’ll also learn about the following:

  • Whether opioids used for pain management result in opioid addiction?
  • Opioid alternatives for pain management

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

Learn About Symptom Relief for Patients with Heart Failure

OSUWexnerbloglogo2014 Learn About Symptom Relief for Patients with Heart Failure. The American Lung Association has a slogan “When you can’t breathe, nothing else matters”. And that is particulary true for patients with end-stage cardiac disease. But the good news is that we have treatment approaches that can help and that is where palliative medicine comes in. I’m pleased to welcomes Associate Professor of Internal Medicine and palliative medicine specialist, Dr. Todd Barrett.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: REVIEW Palliative Care
Domains; and REVIEW Symptom Burden and Treatment in Heart Failure.

You’ll also learn about the following:

  • Heart conditions that benefit from palliative medicine
  • Opioid selection and strategies for use
  • Opioid side effects
  • Fluid management strategies to improve shortness of breath
  • SGLT2 inhibitors
  • Palliative care versus hospice care
  • Incorporating palliative care into usual cardiac care
  • COVID-19 related challenges in providing palliative care

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

CME Webcast Teaches Physicians About Skin Cancer

OSUWexnerbloglogo2014 CME Webcast Teaches Physicians About Skin Cancer. In the 215 years since Laennec discovered melanoma, we have learned an enormous amount about this malignancy and how to best treat it. On this CME webcast, we’re going to update you on the latest information. Joining our moderator are two skin cancer specialists from the James Cancer Hospital. Dr. Joal Beane is a surgical oncologist and Assistant Professor of Surgery at the Ohio State University. And Dr. Carlo Contreras is an Associate Professor of Surgery, also from the OSU Division of Surgical Oncology.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: Describe at least two advantages of neoadjuvant therapy in patients with resectable Stage III/IV melanoma; List the 2 main classes of neoadjuvant therapy in patients with resectable Stage III/IV melanoma; and UNDERSTAND the diagnosis and management of cutaneous melanoma.

You’ll also learn about the following:

  • Subtypes of melanoma
  • Evaluation and diagnosis
  • Indications for referral
  • Role of metastasectomy in advanced melanoma

You can find this and many other MedNet21 programs on the OSU – CCME website.
Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.